Inhibrx Biosciences annual free cash flow
2022
2023
2024
2025
Inhibrx Biosciences Free Cash Flow (FCF) History (INBX)
Inhibrx Biosciences reported −$129.8M in free cash flow for fiscal 2025, an increase of $67.2M from the previous fiscal year, with a free cash flow margin of −9986.54%.
View full Inhibrx Biosciences company overviewInhibrx Biosciences free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$129.8M | $67.2M | — | −9986.54% |
| 2024 | 2024-12-31 | −$197.0M | $896,000 | — | −98503.00% |
| 2023 | 2023-12-31 | −$197.9M | −$106.4M | — | −10994.56% |
| 2022 | 2022-12-31 | −$91.5M | — | — | −7032.82% |
Inhibrx Biosciences quarterly free cash flow
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$29.9M | $36,000 | — | — |
| Q1 2026 | 2026-03-31 | −$38.0M | −$2.1M | — | — |
| Q4 2025 | 2025-12-31 | −$30.1M | — | — | — |
| Q3 2025 | 2025-09-30 | −$33.8M | −$3.3M | — | — |
| Q2 2025 | 2025-06-30 | −$30.0M | $28.6M | — | −2304.08% |
| Q1 2025 | 2025-03-31 | −$35.9M | $28.3M | — | — |
| Q3 2024 | 2024-09-30 | −$30.5M | $24.5M | — | — |
| Q2 2024 · Jun 30 | 2024-06-30 | −$58.6M | — | — | −58573.00% |
| Q1 2024 | 2024-03-31 | −$64.2M | — | — | — |
| Q3 2023 | 2023-09-30 | −$55.1M | — | — | −46265.55% |
Inhibrx Biosciences free cash flow growth trends
Inhibrx Biosciences's latest reported quarter, Q2 2026, generated −$29.9M in free cash flow, an increase of $36,000 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Inhibrx Biosciences source filings ↗